Litcius/Paper detail

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase

Enriqueta Vallejo‐Yagüe, Stefan Weiler, Raphael Micheroli, Andrea M. Burden

2020Drug Safety51 citationsDOI

Topics & Concepts

TofacitinibMedicineOdds ratioInternal medicineConfidence intervalPulmonary embolismThrombosisRheumatoid arthritisRheumatoid Arthritis Research and TherapiesPharmacovigilance and Adverse Drug ReactionsVenous Thromboembolism Diagnosis and Management
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase | Litcius